Home
About
FAQ
History (1)
Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
McCabe NP, Kerr BA, Madajka M, Vasanji A, Byzova TV. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer. Neoplasia. 2011 Jan; 13(1):31-9.
View in:
PubMed
subject areas
Animals
Bone Neoplasms
Bone Resorption
Cell Count
Cell Differentiation
Cell Proliferation
Cells, Cultured
Coculture Techniques
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Neoplasm Transplantation
Osteoclasts
Osteolysis
Osteonectin
Prostatic Neoplasms
Tumor Cells, Cultured